View more in
Cancer

Lucence Presents New Data on Liquid Biopsy for Late-Stage Cancer Monitoring, Treatment Guidance

360dx.com
 2021-06-07

NEW YORK – Precision oncology assay developer Lucence has shared new real-world validation data from two Asian cohorts that it believes demonstrates the ability of its AmpliMark liquid biopsy platform to detect and guide treatment decisions for late-stage cancers. The firm's data also highlighted the assay's use in multiple cancers,...

www.360dx.com

Comments / 0

Comments / 0